Skip to main content

PDE4A (catalytic domain) (human), (recombinant)

BML-SE521

  • BML-SE521-0020   —   20 µg
    $622.00

PDE4A is the primary cAMP metabolizing enzyme and is expressed in many inflammatory cells. Its inhibition attenuates the production of various inflammatory cell functions. It is inhibited by rolipram.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only